Lupin to make equity investment in Sunsure Solarpark

11 Sep 2024 Evaluate

Lupin has signed Share Subscription & Shareholders agreement with Sunsure Solarpark Seventeen (Sunsure Solarpark) and Sunsure Energy (Sunsure) to make equity investment in Sunsure Solarpark. The objective of investment is to purchase renewable power through open access for the Company’s Tarapur manufacturing site. In addition to saving on power costs, the acquisition would enable the Company to fulfill its commitments on decarbonization. 

Upto 42.61% of equity share capital of Sunsure Solarpark to be acquired at a total consideration not exceeding Rs 10.55 crore, to be completed in two tranches, in the capacity as a Captive User.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

Lupin Share Price

2166.10 -12.10 (-0.56%)
20-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.00
Dr. Reddys Lab 1166.90
Cipla 1377.85
Zydus Lifesciences 872.95
Lupin 2166.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×